Related references
Note: Only part of the references are listed.European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update
Morgan Roupret et al.
EUROPEAN UROLOGY (2021)
Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis
Hao Liu et al.
CELL DEATH AND DIFFERENTIATION (2020)
FOXO3a Activation by HDAC Class IIa Inhibition Induces Cell Cycle Arrest in Pancreatic Cancer Cells
Makoto Usami et al.
PANCREAS (2020)
Prognostic value of preoperative blood-based biomarkers in upper tract urothelial carcinoma treated with nephroureterectomy: A systematic review and meta-analysis
Keiichiro Mori et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)
Re: Improving Management of Upper Tract Urothelial Carcinoma
Fredrik Liedberg et al.
EUROPEAN UROLOGY (2020)
Pitavastatin induces apoptosis in oral squamous cell carcinoma through activation of FOXO3a
Naeun Lee et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
FOXO3a acts to suppress DNA double-strand break-induced mutations
Ryan R. White et al.
AGING CELL (2020)
Molecular Characterization of Upper Tract Urothelial Carcinoma in the Era of Next-generation Sequencing: A Systematic Review of the Current Literature
Melanie R. Hassler et al.
EUROPEAN UROLOGY (2020)
Downregulated FOXO3a Associates With Poor Prognosis and Promotes Cell Invasion and Migration via WNT/β-catenin Signaling in Cervical Carcinoma
Yuejun Tian et al.
FRONTIERS IN ONCOLOGY (2020)
EpCAM Signaling Promotes Tumor Progression and Protein Stability of PD-L1 through the EGFR Pathway
Hao-Nien Chen et al.
CANCER RESEARCH (2020)
EMT, MET, Plasticity, and Tumor Metastasis
Basil Bakir et al.
TRENDS IN CELL BIOLOGY (2020)
Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2
Jun Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
A Feedback Loop Formed by ATG7/Autophagy, FOXO3a/miR-145 and PD-L1 Regulates Stem-Like Properties and Invasion in Human Bladder Cancer
Junlan Zhu et al.
CANCERS (2019)
Piperlongumine-induced nuclear translocation of the FOXO3A transcription factor triggers BIM-mediated apoptosis in cancer cells
Zhenxing Liu et al.
BIOCHEMICAL PHARMACOLOGY (2019)
FOXO3a knockdown promotes radioresistance in nasopharyngeal carcinoma by inducing epithelial-mesenchymal transition and the Wnt/β-catenin signaling pathway
Min Luo et al.
CANCER LETTERS (2019)
CSTP1 inhibits IL-6 expression through targeting Akt/FoxO3a signaling pathway in bladder cancer cells
Dexiang Zhuo et al.
EXPERIMENTAL CELL RESEARCH (2019)
FOXO3a from the Nucleus to the Mitochondria: A Round Trip in Cellular Stress Response
Candida Fasano et al.
CELLS (2019)
Arsenic trioxide inhibits angiogenesis in vitro and in vivo by upregulating FoxO3a
Zhuo Sun et al.
TOXICOLOGY LETTERS (2019)
miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting FOXO3a and reverses chemoresistance in hepatocellular carcinoma cells
Yue Zhou et al.
CELL DEATH & DISEASE (2019)
Diagnosis, management, and follow-up of upper tract urothelial carcinoma: an interdisciplinary collaboration between urology and radiology
Jacob L. Roberts et al.
ABDOMINAL RADIOLOGY (2019)
FoxO3a as a Positive Prognostic Marker and a Therapeutic Target in Tamoxifen-Resistant Breast Cancer
Michele Pellegrino et al.
CANCERS (2019)
SIRT3 inhibits prostate cancer metastasis through regulation of FOXO3A by suppressing Wnt/β-catenin pathway
Rong Li et al.
EXPERIMENTAL CELL RESEARCH (2018)
Role of Forkhead Box Class O proteins in cancer progression and metastasis
Chang Geun Kim et al.
SEMINARS IN CANCER BIOLOGY (2018)
hTERT promotes the invasion of gastric cancer cells by enhancing FOXO3a ubiquitination and subsequent ITGB1 upregulation
Changjiang Hu et al.
GUT (2017)
Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis
Zhongrun Qian et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
A review of the PD-1/PD-L1 checkpoint in bladder cancer: From mediator of immune escape to target for treatment
Tian C. Zhou et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
FoxO3a mediates glioma cell invasion by regulating MMP9 expression
Ke Xu et al.
ONCOLOGY REPORTS (2016)
NF-κB-driven suppression of FOXO3a contributes to EGFR mutation-independent gefitinib resistance
Ching-Feng Chiu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
FOXO3a modulates WNT/beta-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells
Hao Liu et al.
CELLULAR SIGNALLING (2015)
Downregulation of FOXO3a Promotes Tumor Metastasis and Is Associated with Metastasis-Free Survival of Patients with Clear Cell Renal Cell Carcinoma
Dong Ni et al.
CLINICAL CANCER RESEARCH (2014)
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
Thomas Powles et al.
NATURE (2014)
Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells
Atsushi Sato et al.
STEM CELL RESEARCH (2014)
Foxo3a Suppression of Urothelial Cancer Invasiveness through Twist1, Y- Box- Binding Protein 1, and E-Cadherin Regulation
Masaki Shiota et al.
CLINICAL CANCER RESEARCH (2010)
FOXO3a Promotes Tumor Cell Invasion through the Induction of Matrix Metalloproteinases
Peter Storz et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Forkhead transcription factors contribute to execution of the mitotic programme in mammals
B Alvarez et al.
NATURE (2001)
Share Paper
